Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy

Drug Discovery Today

Volumn 16, Issue 3-4, 2011, Pages 140-146

  Zhang, Erlong ^a   Zhang, Chao ^a   Su, Yongping ^a   Cheng, Tianmin ^a   Shi, Chunmeng ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; MEMBRANE PROTEIN; MITOCHONDRIAL DNA; NANOPARTICLE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; CANCER GROWTH; CANCER RESEARCH; CANCER THERAPY; CARCINOGENESIS; CELL DAMAGE; CELL METABOLISM; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG TARGETING; GENE MUTATION; HUMAN; LIPOPHILICITY; MITOCHONDRION; REVIEW; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; DRUG DISCOVERY; HUMANS; MITOCHONDRIA; MOLECULAR STRUCTURE; NEOPLASMS;

EID: 79851514312     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2010.12.006     Document Type: Review

References (66)

1. S. Fulda Targeting mitochondria for cancer therapy Nat. Rev. Drug Discov. 9 2010 447 464
2. L. Galluzzi Mitochondrial gateways to cancer Mol. Aspects Med. 31 2010 1 20
3. M.R. Duchen Mitochondria in health and disease: perspectives on a new mitochondrial biology Mol. Aspects Med. 25 2004 365 451 (Pubitemid 39070333)
4. R. Moreno-Sanchez Energy metabolism in tumor cells FEBS J. 274 2007 1393 1418 (Pubitemid 46333738)
5. P. Storz Reactive oxygen species in tumor progression Front. Biosci. 10 2005 1881 1896 (Pubitemid 40529044)
6. H. Pelicano ROS stress in cancer cells and therapeutic implications Drug Resist. Updat. 7 2004 97 110 (Pubitemid 38736063)
7. H. Pelicano Glycolysis inhibition for anticancer treatment Oncogene 25 2006 4633 4646 (Pubitemid 44187614)
8. D.C. Radisky Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability Nature 436 2005 123 127 (Pubitemid 40966197)
9. A. Chatterjee Mitochondrial DNA mutations in human cancer Oncogene 25 2006 4663 4674 (Pubitemid 44187616)
10. K. Ishikawa ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis Science 320 2008 661 664 (Pubitemid 351928347)
11. S. Ohta Contribution of somatic mutations in the mitochondrial genome to the development of cancer and tolerance against anticancer drugs Oncogene 25 2006 4768 4776 (Pubitemid 44187624)
12. G. Kroemer Mitochondrial membrane permeabilization in cell death Physiol. Rev. 87 2007 99 163 (Pubitemid 46209992)
13. N. Sakuragi Bax Bcl-2, and p53 expression in endometrial cancer Gynecol. Oncol. 86 2002 288 296 (Pubitemid 35425524)
14. V. Gogvadze Mitochondria as targets for chemotherapy Apoptosis 14 2009 624 640
15. A.L. Simons 2-Deoxy-d-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells Cancer Res. 67 2007 3364 3370 (Pubitemid 46724876)
16. R.H. Xu Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia Cancer Res. 65 2005 613 621
17. F. Wang Small mitochondria-targeting molecules as anti-cancer agents Mol. Aspects Med. 31 2010 75 92
18. X. Cao Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia Cancer Chemother. Pharmacol. 59 2007 495 505 (Pubitemid 46122328)
19. H. Pelicano Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism J. Biol. Chem. 278 2003 37832 37839 (Pubitemid 37175311)
20. L.F. Dong Alpha-tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II Oncogene 27 2008 4324 4335
21. P. Huang Superoxide dismutase as a target for the selective killing of cancer cells Nature 407 2000 390 395
22. D. Matei Activity of 2 methoxyestradiol (Panzem NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: a Hoosier Oncology Group trial Gynecol. Oncol. 115 2009 90 96
23. A.J. Tevaarwerk Phase I trial of 2-methoxyestradiol NanoCrystal dispersion in advanced solid malignancies Clin. Cancer Res. 15 2009 1460 1465
24. H. Maeda Effective treatment of advanced solid tumors by the combination of arsenic trioxide and l-buthionine-sulfoximine Cell Death Differ. 11 2004 737 746 (Pubitemid 39023120)
25. T. Dragovich Phase I trial of imexon in patients with advanced malignancy J. Clin. Oncol. 25 2007 1779 1784 (Pubitemid 46797961)
26. S. Moulder A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer Invest. New Drugs 28 2010 634 640
27. M.H. Kang, and C.P. Reynolds Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy Clin. Cancer Res. 15 2009 1126 1132
28. M. Vogler A novel paradigm for rapid ABT-737-induced apoptosis involving outer mitochondrial membrane rupture in primary leukemia and lymphoma cells Cell Death Differ. 15 2008 820 830 (Pubitemid 351524424)
29. S.M. O'Brien Phase I to II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in patients with advanced chronic lymphocytic leukemia J. Clin. Oncol. 23 2005 7697 7702 (Pubitemid 46291834)
30. G. Lessene BCL-2 family antagonists for cancer therapy Nat. Rev. Drug Discov. 7 2008 989 1000
31. S. Oudard Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme J. Neurooncol. 63 2003 81 86 (Pubitemid 36681647)
32. A.J. Giurgiovich Elevated mitochondrial cisplatin-DNA adduct levels in rat tissues after transplacental cisplatin exposure Carcinogenesis 18 1997 93 96 (Pubitemid 28134621)
33. M. Okamaoto Ditercalinium chloride, a pro-anticancer drug, intimately associates with mammalian mitochondrial DNA and inhibits its replication Curr. Genet. 43 2003 364 370 (Pubitemid 37021063)
34. E. Segal-Bendirdjian Selective loss of mitochondrial DNA after treatment of cells with ditercalinium (NSC 335153), an antitumor bis-intercalating agent Cancer Res. 48 1988 4982 4992
35. L. Biasutto Mitochondrially targeted anti-cancer agents Mitochondrion 10 2010 670 681
36. L.B. Chen Mitochondrial membrane potential in living cells Annu. Rev. Cell Biol. 4 1988 155 181 (Pubitemid 19139255)
37. S. Davis Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma- derived MCF-7 cells J. Biol. Chem. 260 1985 13844 13850 (Pubitemid 16233244)
38. K.K. Nadakavukaren Increased rhodamine 123 uptake by carcinoma cells Cancer Res. 45 1985 6093 6099 (Pubitemid 16224765)
39. J.S. Modica-Napolitano, and J.R. Aprille Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells Adv. Drug Deliv. Rev. 49 2001 63 70 (Pubitemid 32493800)
40. I.C. Summerhayes Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells Proc. Natl. Acad. Sci. U. S. A. 79 1982 5292 5296 (Pubitemid 12002199)
41. L.F. Yousif Targeting mitochondria with organelle-specific compounds: strategies and applications ChemBioChem 10 2009 1939 1950
42. T.J. Lampidis Effects of the mitochondrial probe rhodamine 123 and related analogs on the function and viability of pulsating myocardial cells in culture Agents Actions 14 1984 751 757 (Pubitemid 14087186)
43. B.A. Teicher Intracellular distribution of a platinum-rhodamine 123 complex in cis-platinum sensitive and resistant human squamous carcinoma cell lines Biochem. Pharmacol. 35 1986 3365 3369 (Pubitemid 16001448)
44. M.F. Ross Cell-penetrating peptides do not cross mitochondrial membranes even when conjugated to a lipophilic cation: evidence against direct passage through phospholipid bilayers Biochem. J. 383 2004 457 468 (Pubitemid 39546115)
45. Y. Yamada, and H. Harashima Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases Adv. Drug Deliv. Rev. 60 2008 1439 1462
46. A. Mukhopadhyay Bacterial signal peptide recognizes HeLa cell mitochondrial import receptors and functions as a mitochondrial leader sequence Cell. Mol. Life Sci. 62 2005 1890 1899 (Pubitemid 41188528)
47. C. Zhang Photosensitisation properties of mitochondrially localised green fluorescent protein Biochem. Biophys. Res. Commun. 242 1998 390 395 (Pubitemid 28412438)
48. M. Esaki Two distinct mechanisms drive protein translocation across the mitochondrial outer membrane in the late step of the Cytochrome b(2) import pathway Proc. Natl. Acad. Sci. U. S. A. 96 1999 11770 11775 (Pubitemid 29502807)
49. L.F. Yousif Mitochondria-penetrating peptides: sequence effects and model cargo transport ChemBioChem 10 2009 2081 2088
50. V. Del Gaizo Targeting proteins to mitochondria using TAT Mol. Genet. Metab. 80 2003 170 180 (Pubitemid 37272243)
51. K. Datta The 104-123 amino acid sequence of the β-domain of von Hippel-Lindau gene product is sufficient to inhibit renal tumor growth and invasion Cancer Res. 61 2001 1768 1775 (Pubitemid 32691981)
52. H.M. Ellerby Anti-cancer activity of targeted pro-apoptotic peptides Nat. Med. 5 1999 1032 1038 (Pubitemid 29439574)
53. K.L. Horton Mitochondria-penetrating peptides Chem. Biol. 15 2008 375 382 (Pubitemid 351508434)
54. V. Weissig Mitochondrial pharmaceutics Mitochondrion 3 2004 229 244 (Pubitemid 38263637)
55. Y. Yamada MITO-Porter: a liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion Biochim. Biophys. Acta 1778 2008 423 432
56. X. Wang Application of nanotechnology in cancer therapy and imaging CA Cancer J. Clin. 58 2008 97 110 (Pubitemid 351521865)
57. B. De Berardis Exposure to ZnO nanoparticles induces oxidative stress and cytotoxicity in human colon carcinoma cells Toxicol. Appl. Pharmacol. 246 2010 116 127
58. Y. Yamada Mitochondrial drug delivery and mitochondrial disease therapy - an approach to liposome-based delivery targeted to mitochondria Mitochondrion 7 2007 63 71 (Pubitemid 46351977)
59. K. Kogure Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method J. Control. Release 98 2004 317 323 (Pubitemid 38950740)
60. N. Nishiyama Enhanced photodynamic cancer treatment by supramolecular nanocarriers charged with dendrimer phthalocyanine J. Control. Release 133 2009 245 251
61. X.-B. Xiong The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin Biomaterials 31 2010 757 768
62. C. Zhang A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging Biomaterials 31 2010 6612 6617
63. C. Zhang Sentinel lymph node mapping by a near-infrared fluorescent heptamethine dye Biomaterials 31 2010 1911 1917
64. O.A. Andreev Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo Proc. Natl. Acad. Sci. U. S. A. 104 2007 7893 7898 (Pubitemid 47185847)
65. X. Yang Near IR heptamethine cyanine dye-mediated cancer imaging Clin. Cancer Res. 16 2010 2833 2844
66. H. Mojzisova Structural and physico-chemical determinants of the interactions of macrocyclic photosensitizers with cells Eur. Biophys. J. 36 2007 943 953 (Pubitemid 350045049)